aspartic acid has been researched along with transforming growth factor beta in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, A; Jin, H; Wright, JA | 1 |
| Glick, AB; Quan, W; Weinberg, WC; Wu, IH; Yuspa, SH | 1 |
| Chytil, A; Datta, PK; Gorska, AE; Moses, HL | 1 |
| Kim, IS; Kim, JE; Kim, KS; Kim, SJ; Lee, BH; Park, RW | 1 |
| Heldin, CH; Landström, M; Pulaski, L; Souchelnytskyi, S | 1 |
| Affeldt, JA; Aldave, AJ; Gutmark, JG; Klintworth, GK; Meallet, MA; Rao, NA; Small, KW; Udar, N; Yellore, VS | 1 |
| Fukuda, A; Iida, A; Ikegawa, S; Kawakami, A; Kizawa, H; Kotani, A; Kou, I; Mabuchi, A; Miyamoto, Y; Nakamura, K; Nakamura, Y; Notoya, K; Sudo, A; Uchida, A; Yamamoto, S | 1 |
| Ikegawa, S | 1 |
| Furuya, T; Hara, T; Imamura, T; Miyazono, K; Shimanuki, T | 1 |
| Correa-Gomez, V; Villalvazo-Cordero, L; Zenteno, JC | 1 |
| Li, D; Lin, H; Qi, Y; Wang, L; Zhao, L; Zhou, N | 1 |
| Chen, L; Gu, Y; Hu, R; Jin, F; Qi, M; Yan, X; Yang, Y; Yu, P | 1 |
| Han, Q; Li, DD; Lin, H; Qi, YH; Zhang, CM; Zhao, LM | 1 |
| Bisceglia, L; De Bonis, P; Laborante, A; Longo, C | 1 |
| Chen, K; Guo, X; Liu, M; Qu, Y; Sun, T; Xiong, Z; Yang, L; Yao, S; Yu, K; Zhou, J | 1 |
| Chida, T; Hanaoka, T; Ito, J; Kawata, K; Kitsugi, K; Matsumoto, M; Neuschwander-Tetri, BA; Noritake, H; Ohta, K; Suda, T; Takatori, S; Ulmasov, B; Umemura, M; Yamashita, M | 1 |
| Brzozowska, E; Deshmukh, S | 1 |
2 review(s) available for aspartic acid and transforming growth factor beta
| Article | Year |
|---|---|
[Asporin, a susceptibility gene for osteoarthritis].
Topics: Alleles; Aspartic Acid; Extracellular Matrix Proteins; Genetic Predisposition to Disease; Humans; Osteoarthritis; Polymorphism, Genetic; Signal Transduction; Transforming Growth Factor beta | 2006 |
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment.
Topics: Antigens, Neoplasm; Arginine; Aspartic Acid; Glycine; Humans; Integrin alphaV; Integrins; Neoplasms; Oligopeptides; Transforming Growth Factor beta | 2022 |
15 other study(ies) available for aspartic acid and transforming growth factor beta
| Article | Year |
|---|---|
Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Blotting, Southern; Cell Division; Cell Line; Drug Resistance; Gene Amplification; Gene Expression; Mice; Phosphonoacetic Acid; Recombinant Proteins; Swine; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1995 |
Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.
Topics: Animals; Aspartic Acid; Cells, Cultured; G1 Phase; Gene Amplification; Genes, p53; Genes, Retinoblastoma; Mice; Phosphonoacetic Acid; Transforming Growth Factor beta | 1996 |
Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Aspartic Acid; Cloning, Molecular; Mice; Molecular Sequence Data; Protein Binding; Proteins; Receptors, Growth Factor; Receptors, Transforming Growth Factor beta; RNA-Binding Proteins; Signal Transduction; Transcriptional Activation; Transforming Growth Factor beta; Tryptophan | 1998 |
Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Cell Adhesion; Cell Separation; Conserved Sequence; Cornea; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Epithelial Cells; Extracellular Matrix Proteins; Fibronectins; Flow Cytometry; Humans; Integrins; Isoleucine; K562 Cells; Models, Genetic; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasm Proteins; Peptides; Precipitin Tests; Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid; Serum Albumin, Bovine; Transfection; Transforming Growth Factor beta | 2000 |
Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Aspartic Acid; Bone Morphogenetic Proteins; Cell Nucleus; COS Cells; DNA; DNA-Binding Proteins; Genes, Reporter; Ligands; Luciferases; Mice; Microscopy, Fluorescence; Molecular Sequence Data; Mutation; Phosphorylation; Promoter Regions, Genetic; Protein Structure, Tertiary; Serine; Signal Transduction; Smad7 Protein; Time Factors; Trans-Activators; Transcription, Genetic; Transcriptional Activation; Transfection; Transforming Growth Factor beta | 2001 |
Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene.
Topics: Adult; Alanine; Amyloid; Amyloidosis; Aspartic Acid; Cornea; Corneal Dystrophies, Hereditary; DNA Mutational Analysis; Exons; Extracellular Matrix Proteins; Female; Glutamine; Haplotypes; Humans; Mutation, Missense; Pedigree; Proline; Transforming Growth Factor beta | 2004 |
An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis.
Topics: Aggrecans; Aspartic Acid; Carrier Proteins; Chondrogenesis; Chromosome Mapping; Disease Susceptibility; Extracellular Matrix Proteins; Glycoproteins; Humans; In Vitro Techniques; Lectins, C-Type; Minisatellite Repeats; Molecular Sequence Data; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Polymorphism, Genetic; Proteoglycans; Transforming Growth Factor beta | 2005 |
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Binding Sites; Cell Line; Cell Proliferation; Chlorocebus aethiops; Conserved Sequence; Glutamic Acid; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Mutation; Protein Structure, Quaternary; Protein Structure, Tertiary; Receptors, Transforming Growth Factor beta; Sequence Alignment; Signal Transduction; Transforming Growth Factor beta | 2007 |
The TGFBI A546D mutation causes an atypical type of lattice corneal dystrophy.
Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Base Sequence; Child; Child, Preschool; Cornea; Corneal Dystrophies, Hereditary; Exons; Extracellular Matrix Proteins; Female; Genes, Dominant; Heterozygote; Humans; Infant; Male; Middle Aged; Pedigree; Phenotype; Point Mutation; Transforming Growth Factor beta | 2007 |
An atypical phenotype of Reis-Bücklers corneal dystrophy caused by the G623D mutation in TGFBI.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Aspartic Acid; Base Sequence; Cornea; Corneal Dystrophies, Hereditary; DNA Mutational Analysis; Exons; Extracellular Matrix Proteins; Female; Glycine; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Phenotype; Transforming Growth Factor beta | 2008 |
p.Ala546 > Asp and p.Arg555 > Trp mutations of TGFBI gene and their clinical manifestations in two large Chinese families with granular corneal dystrophy type I.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Asian People; Aspartic Acid; Case-Control Studies; Corneal Dystrophies, Hereditary; DNA Mutational Analysis; Extracellular Matrix Proteins; Family; Female; Humans; Male; Middle Aged; Mutation, Missense; Pedigree; Transforming Growth Factor beta; Tryptophan; Young Adult | 2008 |
[Analysis of TGFBI gene mutation in a Chinese family with atypical Reis-Buckler corneal dystrophy].
Topics: Asian People; Aspartic Acid; Corneal Dystrophies, Hereditary; Corneal Stroma; Exons; Extracellular Matrix Proteins; Family; Female; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Male; Pedigree; Phenotype; Sequence Analysis, DNA; Transforming Growth Factor beta | 2009 |
Lattice Corneal Dystrophy-Variant: a report of three new cases due to p.V631D mutation in the TGFBI gene.
Topics: Aspartic Acid; Biomarkers; Corneal Dystrophies, Hereditary; Early Diagnosis; Extracellular Matrix Proteins; Humans; Point Mutation; Prognosis; Transforming Growth Factor beta; Valine | 2013 |
Creation of Bony Microenvironment with Extracellular Matrix Doped-Bioactive Ceramics to Enhance Osteoblast Behavior and Delivery of Aspartic Acid-Modified BMP-2 Peptides.
Topics: Animals; Aspartic Acid; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Ceramics; Extracellular Matrix; Gene Expression Regulation; Kinetics; Male; Mice; Osteoblasts; Osteogenesis; Peptides; Porosity; Rats, Sprague-Dawley; Recombinant Proteins; Swine; Tissue Scaffolds; Transforming Growth Factor beta | 2020 |
Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway.
Topics: Arginine; Aspartic Acid; Focal Adhesion Protein-Tyrosine Kinases; Glycine; Hepatic Stellate Cells; Hippo Signaling Pathway; Humans; Integrins; Liver Cirrhosis; Oligopeptides; Phosphatidylinositols; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Transforming Growth Factor beta; YAP-Signaling Proteins | 2022 |